Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Brain size and white matter content of cerebrospinal tracts determine the upper cervical cord area: evidence from structural brain MRI.
Generation of an immortalized murine brain microvascular endothelial cell line as an in vitro blood brain barrier model.
[Vitamin D and multiple sclerosis : The role for risk of disease and treatment.]
A novel immunomodulator, FTY-720 reverses existing cardiac hypertrophy and fibrosis from pressure overload by targeting NFAT (nuclear factor of activated T-cells) signaling and periostin.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging.
Blocking A2B Adenosine Receptor Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis via Inhibition of IL-6 Production and Th17 Differentiation.
Changes in Th17 and regulatory T cells after fingolimod initiation to treat multiple sclerosis.
Multiple Sclerosis: A Disease of Affluence?.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Increased Th17 response to myelin peptides in pediatric MS.
A qualitative study of the childbearing experience of women living with multiple sclerosis.
Multiple sclerosis during adalimumab treatment in a case with ankylosing spondylitis.
Therapeutic Potential of Cannabinoids in Neurodegenerative Disorders: A Selective Review.
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
Isolation & characterization of Bartonella sp. from optic neuritis patients.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS
MHC-mismatched mixed chimerism augments thymic regulatory T-cell production and prevents relapse of EAE in mice.
Review of Animal Models of Neuromyelitis Optica.
[von Willebrand factor and adhesion molecules in patients with multiple sclerosis.]
New TYSABRI® analysis at AAN annual meeting shows improved walking speed in significant number of MS patients
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Corrigendum.
Comparison of Two Molecular Scaffolds, 5-Methylisoxazole-3-Carboxamide and 5-Methylisoxazole-4-Carboxamide.
A case of prolonged delayed postdural puncture headache in a patient with multiple sclerosis exacerbated by air travel.
Pages
« first
‹ previous
…
235
236
237
238
239
240
241
242
243
…
next ›
last »